These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14677774)

  • 1. Characterization of excipient and tableting factors that influence folic acid dissolution, friability, and breaking strength of oil- and water-soluble multivitamin with minerals tablets.
    Du J; Hoag SW
    Drug Dev Ind Pharm; 2003 Nov; 29(10):1137-47. PubMed ID: 14677774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
    Zaheer K; Langguth P
    Eur J Pharm Biopharm; 2019 Jun; 139():177-185. PubMed ID: 30902732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tablet solubility and hygroscopicity on disintegrant efficiency in direct compression tablets in terms of dissolution.
    Gordon MS; Chowhan ZT
    J Pharm Sci; 1987 Dec; 76(12):907-9. PubMed ID: 3440935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
    Meka VS; Yee P; Sheshala R
    Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of prescription prenatal vitamin products to meet USP standards for folic acid dissolution.
    Hoag SW; Ramachandruni H; Shangraw RF
    J Am Pharm Assoc (Wash); 1997; NS37(4):397-400. PubMed ID: 9519649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a controlled release formulation by continuous twin screw granulation: Influence of process and formulation parameters.
    Vanhoorne V; Vanbillemont B; Vercruysse J; De Leersnyder F; Gomes P; Beer TD; Remon JP; Vervaet C
    Int J Pharm; 2016 May; 505(1-2):61-8. PubMed ID: 27041123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of drug load on dissolution behavior of tablets containing a poorly water-soluble drug: estimation of the percolation threshold.
    Wenzel T; Stillhart C; Kleinebudde P; Szepes A
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1265-1275. PubMed ID: 28398095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant.
    Rohrs BR; Thamann TJ; Gao P; Stelzer DJ; Bergren MS; Chao RS
    Pharm Res; 1999 Dec; 16(12):1850-6. PubMed ID: 10644073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
    Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
    Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pH on the dissolution of folic acid supplements.
    Younis IR; Stamatakis MK; Callery PS; Meyer-Stout PJ
    Int J Pharm; 2009 Feb; 367(1-2):97-102. PubMed ID: 18929632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of intra- and extragranular microcrystalline cellulose in tablet dissolution.
    Li JZ; Rekhi GS; Augsburger LL; Shangraw RF
    Pharm Dev Technol; 1996 Dec; 1(4):343-55. PubMed ID: 9552318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the mode of croscarmellose sodium incorporation on tablet dissolution and friability.
    Gordon MS; Chatterjee B; Chowhan ZT
    J Pharm Sci; 1990 Jan; 79(1):43-7. PubMed ID: 2313575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competing for water: A new approach to understand disintegrant performance.
    Ekmekciyan N; Tuglu T; El-Saleh F; Muehlenfeld C; Stoyanov E; Quodbach J
    Int J Pharm; 2018 Sep; 548(1):491-499. PubMed ID: 30018010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of formulation solubility and hygroscopicity on disintegrant efficiency in tablets prepared by wet granulation, in terms of dissolution.
    Johnson JR; Wang LH; Gordon MS; Chowhan ZT
    J Pharm Sci; 1991 May; 80(5):469-71. PubMed ID: 1880728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Punch geometry and formulation considerations in reducing tablet friability and their effect on in vitro dissolution.
    Chowhan ZT; Amaro AA; Ong JT
    J Pharm Sci; 1992 Mar; 81(3):290-4. PubMed ID: 1640370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach to support formulation design on twin screw wet granulation technology: Understanding the impact of overarching excipient properties on drug product quality attributes.
    Willecke N; Szepes A; Wunderlich M; Remon JP; Vervaet C; De Beer T
    Int J Pharm; 2018 Jul; 545(1-2):128-143. PubMed ID: 29684559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.